2023年的“进博宝宝”锐珂，不光是全球首个针对非小细胞肺癌的双抗，还暗藏着强生从自免、血液瘤霸主，向实体瘤进发的野心。你听说过“泡泡宝贝”吗？不是吹泡泡的可爱宝宝，是被I型神经纤维瘤缠上的孩子，有的才5 岁，胳膊上的丛状肿瘤磨得穿衣服都哭，有的因为肿瘤压迫神经，握不住笔、跑不了步，有的就算做了手术，疼痛和功能受限还会伴随终生。以前这些孩子，连“有药可用”都是奢望，直到2023年，一个“进博宝宝”...
Source Link2023年的“进博宝宝”锐珂，不光是全球首个针对非小细胞肺癌的双抗，还暗藏着强生从自免、血液瘤霸主，向实体瘤进发的野心。你听说过“泡泡宝贝”吗？不是吹泡泡的可爱宝宝，是被I型神经纤维瘤缠上的孩子，有的才5 岁，胳膊上的丛状肿瘤磨得穿衣服都哭，有的因为肿瘤压迫神经，握不住笔、跑不了步，有的就算做了手术，疼痛和功能受限还会伴随终生。以前这些孩子，连“有药可用”都是奢望，直到2023年，一个“进博宝宝”...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.